Laurel Wealth Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,875
Closed -$146K 140
2022
Q4
$146K Hold
1,875
0.09% 67
2022
Q3
$151K Sell
1,875
-25
-1% -$2.25K 0.11% 62
2022
Q2
$171K Sell
1,900
-600
-24% -$60.8K 0.12% 65
2022
Q1
$277K Buy
+2,500
New +$264K 0.19% 59

Other funds holding MDT

Laurel Wealth Planning's MDT Position: Q1 2023 in Review

Laurel Wealth Planning sold out of Medtronic (MDT) in Q1 2023, closing a stake of 1,875 shares — an estimated $146K sold.

Laurel Wealth Planning first reported a position in MDT in Q1 2022 and held it in 4 quarters. The position peaked at $277K in Q1 2022. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Laurel Wealth Planning reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Laurel Wealth Planning sold 1,875 Medtronic shares in Q1 2023, an estimated $146K.
  • Laurel Wealth Planning first reported a position in Medtronic in Q1 2022 and held it in 4 quarters.
  • Laurel Wealth Planning's Medtronic position peaked at $277K in Q1 2022.
  • 1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Laurel Wealth Planning's 13F filing for Q1 2023, filed 18 Apr 2023.